Category Archives: Health Care

M42 Announces Strategic Investment and Partnership with Leading Biotech Juvenescence

  • M42 and Juvenescence will collaborate in drug discovery to develop a pipeline of innovative medicines to advance the prevention and treatment of diseases of high unmet need within UAE and globally and age-related diseases
  • The strategic partnership aligns with M42’s newly launched AI Life Sciences Platform
  • M42’s strategic investment in Juvenescence will accelerate Juvenescence’s clinical pipeline and drug development capabilities which underscores this collaboration
  • Expansion of capabilities in AI-enabled therapeutics underlines Abu Dhabi’s vision of becoming a global hub for AI-driven longevity science and next-generation drug development
Continue reading M42 Announces Strategic Investment and Partnership with Leading Biotech Juvenescence

ADIO, DoH and Hub71 join forces to position Abu Dhabi as global epicentre for life sciences investment

  • Strategic partnership set to drive accelerated growth, attract global venture capital and empower groundbreaking HealthTech through Abu Dhabi’s new Health, Endurance, Longevity, and Medicine (HELM) cluster

Abu Dhabi, UAE – 17 April 2025:  The Abu Dhabi Investment Office (ADIO) and the Department of Health – Abu Dhabi (DoH), the regulator of the health sector in the Emirate of Abu Dhabi, today announced the signing of a strategic partnership with Hub71, Abu Dhabi’s global tech ecosystem, to attract global venture capital (VC) investment and accelerate the growth of HealthTech and life sciences startups through the emirate’s newly launched Health, Endurance, Longevity, and Medicine (HELM) cluster. Led by the Abu Dhabi Department of Economic Development (ADDED), ADIO and DoH, the HELM cluster was established to be a global hub for biotechnology, MedTech and digital health innovation. The cluster is projected to contribute AED 94 billion to Abu Dhabi’s GDP and create 30,000 new jobs by 2045.

Continue reading ADIO, DoH and Hub71 join forces to position Abu Dhabi as global epicentre for life sciences investment

ISPOR UAE Chapter and AbbVie Announce Intent to Collaborate on Healthcare Advancement at Abu Dhabi Global Health Week

Abu Dhabi, UAE: The ISPOR UAE Chapter, the local chapter of the leading international scientific and educational organization for health economics and outcomes research (HEOR), and AbbVie, a global biopharmaceutical company, today announced their intent to explore collaborative opportunities aimed at enhancing healthcare outcomes in the UAE. The Letter of Intent (LOI) was signed during the Abu Dhabi Global Health Week in the presence of senior board members from the ISPOR UAE Chapter and senior leadership from AbbVie Gulf.

Continue reading ISPOR UAE Chapter and AbbVie Announce Intent to Collaborate on Healthcare Advancement at Abu Dhabi Global Health Week

Thumbay International Research Grant 1st Cycle Concludes with Resounding Success:

Thumbay International Research Grant 1st Cycle Concludes with Resounding Success: 192 Applications from 34 Universities, 14 Projects Awarded at Grand Ceremony in Ajman

Ajman, UAE– Gulf Medical University (GMU), Ajman, celebrated the outstanding success of the inaugural Thumbay International Research Grant (TIRG)at a grand award ceremony held on April 15, 2025, coinciding with GMU’s Annual Research Day. The groundbreaking initiative, supported by Thumbay Group UAE, attracted global attention for its mission to drive impactful healthcare research through international collaboration and innovation.

Continue reading Thumbay International Research Grant 1st Cycle Concludes with Resounding Success:

M42’s NRL and Neurocode International launch region-first Center for Advanced Neuro Biochemical Diagnostics

  • Equipped with world-class laboratory equipment and staffed by renowned neurologists and pathologists, the Center for Advanced Neuro Biochemical Diagnostics will offer non-invasive testing for patients as young as 40, enabling early detection and helping reduce Alzheimer’s cases in the UAE and the wider region

Abu Dhabi, United Arab Emirates. April 16, 2025: Setting a new regional benchmark in the fight against Alzheimer’s disease, the National Reference Laboratory (NRL), part of the M42 Group, is establishing the MENA region’s first Center for Advanced Neuro Biochemical Diagnostics dedicated to early detection, in partnership with Neurocode International, global leader of neurology diagnostic solutions. Announced on the sidelines of Abu Dhabi Global Health Week, this Center for Advanced Neuro Biochemical Diagnostics, based in Abu Dhabi, is a pioneering step toward reducing Alzheimer’s cases in the UAE and wider region and transforming neurological diagnostics worldwide.

Continue reading M42’s NRL and Neurocode International launch region-first Center for Advanced Neuro Biochemical Diagnostics